Two of the distinguished in the latest edition of the Fronteras del Conocimiento FBBVA, endocrinologist Daniel J. Drucker and ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

King Charles Edinburgh today: Monarch presented with keys to Scottish capital at Palace of Holyroodhouse ...

An uncomfortable reality in Scotland today is that too many young children are at risk of obesity. A quarter will be classed as overweight by the time they start primary school. A new report warns ...

Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...

Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

The most frustrating part about MASLD is that this serious illness can be reversed with early identification and treatment.

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

While we’re often told to think positively, many of life’s biggest problems—like obesity, debt, and dangerous habits—stem ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.